Interclean Shanghai

Industry Updates

Vital Launches Application Neutral Architecture to Deliver Advanced...

Vital Images, Inc a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the launch of the latest addition to its enterprise clinical...

Sanofi, Boehringer Ingelheim agree to swap animal health,...

Sanofi and Boehringer Ingelheim announced the signing of contracts to secure the strategic transaction initiated in December  2015 which consists of an exchange of Sanofi’s...

Daiichi Sankyo Enters Into Agreement with Servier Canada...

Daiichi Sankyo Co Limited announced that it has entered into an agreement with Servier Canada whereby Servier Canada will market the oral, once-daily anti-coagulant edoxaban...

Takeda Revises Collaboration Agreement with Amgen to Returns...

Takeda Pharmaceutical Company Limited announced revisions on an existing collaboration agreement, under which Takeda had rights to develop and commercialize multiple molecules / products from...

St Jude Medical Expands Portfolio with New CRT...

St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies. ...

EC grants marketing authorisation to Odefsey in HIV

Gilead Sciences, Inc announced that the EC hs granted marketing authorization for the once-daily single tablet regimen (STR) Odefsey®(emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25...

Allergan Plc Receives FDA Approval for AVYCAZ sNDA

Allergan plc a leading global pharmaceutical company, announced the U.S. FDA has approved the company's supplemental New Drug Application (sNDA) to update the label for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »